Evotec SE (EVO) Capital Expenditures Growth (1y) (2022 - 2026)
Evotec SE (EVO) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 32.28% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3,566.67% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 113.56% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.95% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -21.54% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -59.55% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -76.65% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -84.04% |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 74.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.54% |
| Dec 31, 2025 | -32.73% |
| Sep 30, 2025 | 19.66% |
| Jun 30, 2025 | 42.04% |
| Mar 31, 2025 | 56.21% |
| Dec 31, 2024 | -45.30% |
| Sep 30, 2024 | 41.18% |
| Jun 30, 2024 | 76.31% |
| Mar 31, 2024 | -194.47% |
| Dec 31, 2023 | 24.24% |
| Sep 30, 2023 | -120.78% |
| Jun 30, 2023 | -290.52% |
| Mar 31, 2023 | 196.05% |
| Dec 31, 2022 | 35.98% |
| Sep 30, 2022 | 638.80% |
| Jun 30, 2022 | -146.92% |
| Mar 31, 2022 | -109,924.74% |